{"id":4501,"date":"2026-02-17T08:56:43","date_gmt":"2026-02-17T13:56:43","guid":{"rendered":"https:\/\/happylungsproject.org\/?p=4501"},"modified":"2026-03-02T10:52:34","modified_gmt":"2026-03-02T15:52:34","slug":"positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer","status":"publish","type":"post","link":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/","title":{"rendered":"Positive Results for Selpercatinib for Early Stage-RET Lung Cancer"},"content":{"rendered":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” row_position_desktop=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” flex_gap_desktop=”10px” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_row_inner column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” text_align=”left” row_position=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” pointer_events=”all”][vc_column_inner column_padding=”padding-3-percent” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” flex_gap_desktop=”10px” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color=”#f68d28″ background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” font_color=”#ffffff” column_shadow=”none” column_border_radius=”10px” column_link_target=”_self” overflow=”visible” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid” column_padding_type=”default” gradient_type=”default”][vc_column_text css=”” text_direction=”default”]\n

Eli Lilly and Company announced positive results from the Phase 3 LIBRETTO-432 clinical trial evaluating Retevmo\u00ae (selpercatinib) as adjuvant therapy versus placebo in early-stage (II\u2013IIIA) RET fusion-positive lung cancer.<\/p>\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” text_align=”left” row_position=”default” row_position_tablet=”inherit” row_position_phone=”inherit” overflow=”visible” pointer_events=”all”][vc_column_inner column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” flex_gap_desktop=”10px” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” overflow=”visible” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][vc_column_text css=”” text_direction=”default”]Selpercatinib showed a statistically significant improvement in event-free survival (EFS) as adjuvant therapy in patients with early-stage RET fusion-positive NSCLC. Overall survival trended positively (data immature), and safety was consistent with prior trials.<\/p>\n

Detailed results will be shared at an upcoming medical meeting.<\/p>\n

These results also reinforce the importance of genomic testing at diagnosis. Identifying RET fusions helps ensure patients can access personalized treatments designed for their cancer.\u00a0Advances like this bring hope and move us closer to better outcomes for people living with early stage RET-positive lung cancer.<\/p>\n

Read more:\u00a0https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-retevmo-selpercatinib-delivers-substantial-event-free<\/a><\/p>\n

LIBRETTO-432 clinical trial:\u00a0https:\/\/clinicaltrials.gov\/study\/NCT04819100<\/a><\/p>\nView all RET clinical trials<\/span><\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"

Eli Lilly and Company announced positive results from the Phase 3 LIBRETTO-432 clinical trial evaluating Retevmo\u00ae (selpercatinib) as adjuvant therapy versus placebo in early-stage (II\u2013IIIA) RET fusion-positive lung cancer.<\/p>\n","protected":false},"author":15,"featured_media":2623,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,20],"tags":[],"class_list":{"0":"post-4501","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-clinical-trials","8":"category-treatment"},"yoast_head":"\nPositive results for selpercatinib for early stage-RET lung cancer<\/title>\n<meta name=\"description\" content=\"Eli Lilly announced positive results LIBRETTO-432 clinical trial, Retevmo\u00ae (selpercatinib) in early-stage RET fusion-positive lung cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Positive results for selpercatinib for early stage-RET lung cancer\" \/>\n<meta property=\"og:description\" content=\"Eli Lilly announced positive results LIBRETTO-432 clinical trial, Retevmo\u00ae (selpercatinib) in early-stage RET fusion-positive lung cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"The Happy Lungs Project\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thehappylungsproject\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-17T13:56:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-02T15:52:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"994\" \/>\n\t<meta property=\"og:image:height\" content=\"651\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Irene Guijarro Munoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Irene Guijarro Munoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/\"},\"author\":{\"name\":\"Irene Guijarro Munoz\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\"},\"headline\":\"Positive Results for Selpercatinib for Early Stage-RET Lung Cancer\",\"datePublished\":\"2026-02-17T13:56:43+00:00\",\"dateModified\":\"2026-03-02T15:52:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/\"},\"wordCount\":654,\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg\",\"articleSection\":[\"Clinical Trials\",\"Treatment\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/\",\"url\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/\",\"name\":\"Positive results for selpercatinib for early stage-RET lung cancer\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg\",\"datePublished\":\"2026-02-17T13:56:43+00:00\",\"dateModified\":\"2026-03-02T15:52:34+00:00\",\"description\":\"Eli Lilly announced positive results LIBRETTO-432 clinical trial, Retevmo\u00ae (selpercatinib) in early-stage RET fusion-positive lung cancer.\",\"breadcrumb\":{\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#primaryimage\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg\",\"width\":994,\"height\":651,\"caption\":\"Lilly pharmaceutical clinical trial\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/happylungsproject.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Positive Results for Selpercatinib for Early Stage-RET Lung Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/happylungsproject.org\/#website\",\"url\":\"https:\/\/happylungsproject.org\/\",\"name\":\"The Happy Lungs Project\",\"description\":\"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.\",\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/happylungsproject.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/happylungsproject.org\/#organization\",\"name\":\"The Happy Lungs Project\",\"url\":\"https:\/\/happylungsproject.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"width\":1500,\"height\":1575,\"caption\":\"The Happy Lungs Project\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/thehappylungsproject\",\"https:\/\/www.instagram.com\/thehappylungsproject\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\",\"name\":\"Irene Guijarro Munoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"caption\":\"Irene Guijarro Munoz\"},\"description\":\"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.\",\"sameAs\":[\"https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Positive results for selpercatinib for early stage-RET lung cancer","description":"Eli Lilly announced positive results LIBRETTO-432 clinical trial, Retevmo\u00ae (selpercatinib) in early-stage RET fusion-positive lung cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Positive results for selpercatinib for early stage-RET lung cancer","og_description":"Eli Lilly announced positive results LIBRETTO-432 clinical trial, Retevmo\u00ae (selpercatinib) in early-stage RET fusion-positive lung cancer.","og_url":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/","og_site_name":"The Happy Lungs Project","article_publisher":"https:\/\/www.facebook.com\/thehappylungsproject","article_published_time":"2026-02-17T13:56:43+00:00","article_modified_time":"2026-03-02T15:52:34+00:00","og_image":[{"width":994,"height":651,"url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg","type":"image\/jpeg"}],"author":"Irene Guijarro Munoz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Irene Guijarro Munoz","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#article","isPartOf":{"@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/"},"author":{"name":"Irene Guijarro Munoz","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b"},"headline":"Positive Results for Selpercatinib for Early Stage-RET Lung Cancer","datePublished":"2026-02-17T13:56:43+00:00","dateModified":"2026-03-02T15:52:34+00:00","mainEntityOfPage":{"@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/"},"wordCount":654,"publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"image":{"@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg","articleSection":["Clinical Trials","Treatment"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/","url":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/","name":"Positive results for selpercatinib for early stage-RET lung cancer","isPartOf":{"@id":"https:\/\/happylungsproject.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#primaryimage"},"image":{"@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg","datePublished":"2026-02-17T13:56:43+00:00","dateModified":"2026-03-02T15:52:34+00:00","description":"Eli Lilly announced positive results LIBRETTO-432 clinical trial, Retevmo\u00ae (selpercatinib) in early-stage RET fusion-positive lung cancer.","breadcrumb":{"@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#primaryimage","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2024\/05\/lilly-pharmaceutical.jpg","width":994,"height":651,"caption":"Lilly pharmaceutical clinical trial"},{"@type":"BreadcrumbList","@id":"https:\/\/happylungsproject.org\/positive-results-for-selpercatinib-for-early-stage-ret-lung-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/happylungsproject.org\/"},{"@type":"ListItem","position":2,"name":"Positive Results for Selpercatinib for Early Stage-RET Lung Cancer"}]},{"@type":"WebSite","@id":"https:\/\/happylungsproject.org\/#website","url":"https:\/\/happylungsproject.org\/","name":"The Happy Lungs Project","description":"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.","publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/happylungsproject.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/happylungsproject.org\/#organization","name":"The Happy Lungs Project","url":"https:\/\/happylungsproject.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","width":1500,"height":1575,"caption":"The Happy Lungs Project"},"image":{"@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thehappylungsproject","https:\/\/www.instagram.com\/thehappylungsproject\/"]},{"@type":"Person","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b","name":"Irene Guijarro Munoz","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","caption":"Irene Guijarro Munoz"},"description":"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.","sameAs":["https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/4501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/comments?post=4501"}],"version-history":[{"count":5,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/4501\/revisions"}],"predecessor-version":[{"id":4506,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/4501\/revisions\/4506"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media\/2623"}],"wp:attachment":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media?parent=4501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/categories?post=4501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/tags?post=4501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}